Breast cancer (BC) is a common and heterogeneous disease, of which six molecular
subtypes, characterized by different biological features and clinical outcomes, were …

Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

Breast cancer is the second most common cause of deaths reported in women worldwide,
and therefore there is a need to identify breast cancer patients at an early stage as timely …

Simple Summary In the era of precision medicine, new tools for better management of breast
cancer patients are still needed. From this perspective, circulating microRNA (miRNA), a …

Breast cancer (BC) is the most frequent type of non skin cancer among women and a major
leading cause of cancer-related deaths in Western countries. It is substantial to discover …

Breast cancer (BC) is one of the widespread lethal diseases affecting a large number of
women worldwide. As such, employing and identifying significant markers for detecting BC …

Breast cancer is the second most common malignancy diagnosed in women, supporting the
need for identification of novel prognostic and diagnostic biomarkers. Recently, microRNAs …

The effective management of patients with breast cancer (BC) depends on the early
diagnosis of the disease. Currently, BC diagnosis is based on diagnostic imaging and …

MicroRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking
translation of messenger RNA targets, these non-coding RNAs can modulate the expression …

This study aimed at investigating the expression of candidate microRNAs (miRs), at initial
diagnosis, during neoadjuvant chemotherapy, and after the tumor resection in locally …